In this study, we aimed to explore the molecular and cellular characteristics associated with FOXA1 mutant prostate cancer and identify potential therapeutic targets and candidate drugs that may hold promise for improved treatment approaches. The gene discussed is FOXA1; the disease is prostate carcinoma.